35615-98-6

Basic information

• Product Name: methyl 4-methyl-1-naphthoate
• Synonyms: methyl 4-methyl-1-naphthoate;4-Methyl-naphthalene-1-carboxylic acid methyl ester
• CAS NO: 35615-98-6
• Molecular Formula: C₁₃H₁₂O₂
• Molecular Weight: 200.23318
• Mol File: 35615-98-6.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 323.7±11.0 °C(Predicted)
• Appearance: /
• Density: 1.126±0.06 g/cm3(Predicted)
• CAS DataBase Reference: methyl 4-methyl-1-naphthoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-methyl-1-naphthoate(35615-98-6)
• EPA Substance Registry System: methyl 4-methyl-1-naphthoate(35615-98-6)

Safety Data

• Hazardous Substances Data: 35615-98-6(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 4488-40-8 4-Methyl-1-naphthoic acid 
• 124-38-9 carbon dioxide 
• 115913-58-1 1-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-4-methyl naphtalene 
• 67-56-1 methanol 
• 87700-67-2 4-methyl-1-naphthalenecarbonyl chloride 
• 90-12-0 1-Methylnaphthalene 
• 2417-75-6 methyl 4-bromomethylnaphthalene-1-carboxylate 
• 74-88-4 methyl iodide 

Downstream Products

• 2417-75-6 methyl 4-bromomethylnaphthalene-1-carboxylate 
• 502924-66-5 2-(4-methylnaphthalene-1-carbonyl)acetonitrile 
• 1001200-41-4 methyl 4-(dibromomethyl)naphthalene-1-carboxylate 
• 1367282-96-9 (E/Z)-4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-(ethoxyimino)ethyl)-1-naphthamide 
• 1367282-98-1 (E/Z)-4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2((2-fluoroethoxy)imino)ethyl)-1-naphthamide 
• 1367283-00-8 (E/Z)-N-(2-((cyclopropylmethoxy)imino)ethyl)-4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-1-naphthamide 
• 1367283-12-2 methyl 4-[5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxylate 
• 1308351-00-9 4-[5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxylic acid 
• 1095960-79-4 4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-hydroxyethyl)-1-naphthamide 
• 1367283-14-4 4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-oxoethyl)-1-naphthamide 
• 1095960-89-6 4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(3,3,3-trifluoro-2-hydroxypropyl)-1-naphthamide 
• 1367282-60-7 (Z)-4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-(isopropoxyimino)ethyl)-1-naphthamide 
• 1367282-58-3 (E)-4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-(isopropoxyimino)ethyl)-1-naphthamide 
• 219685-15-1 4-formylnaphthalene-1-carboxylic acid 

Relevant articles and documents

Palladium-Catalyzed Regiospecific peri- And ortho-C-H Oxygenations of Polyaromatic Rings Mediated by Tunable Directing Groups

An efficient divergent approach of Pd-catalyzed C-H oxygenation of polyaromatic rings is described. Reversible directing groups enable regiospecific peri- and ortho-oxygenation to readily access a wide array of polyaromatic phenols without pre- and postmanipulation of directing groups. The systematic mechanistic investigation, including deuterium-labeling experiments, palladacycle trapping, and DFT calculations, reveals that the tunable ligand-assisted C-H bond cleavage played a crucial role during the reaction process.

RENIN INHIBITORS

Disclosed are compounds of Formula (I) wherein the R, R1, R2, R3, X, Y, A, Q, E, and G are defined herein. These compounds bind to aspartic proteases to inhibit their activity and are useful in the treatment or amelioration of diseases associated with aspartic protease activity. Also disclosed are methods of use of the compounds of Formula I for ameliorating or treating aspartic protease related disorders in a subject in need thereof.

CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND

To provide novel nitrogen-containing compounds having antagonism to CXCR4 and remedies for disease, such as rheumatism, cancer metastasis, etc., based on the CXCR4 antagonism. Nitrogen-containing compounds represented by the following general formula and